Magnetic resonance imaging of pediatric muscular disorders. Recent advances and clinical applications.

Radiologic Clinics of North America

Volumn 51, Issue 4, 2013, Pages 721-742

  Kim, Hee Kyung ^a   Lindquist, Diana M ^a   Serai, Suraj D ^a   Mariappan, Yogesh K ^b   Wang, Lily L ^a   Merrow, Arnold C ^a   McGee, Kiaran P ^b   Ehman, Richard L ^b   Laor, Tal ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Diffusion tensor imaging; Diffusion weighted imaging; Dixon imaging; Magnetic resonance elastography; Magnetic resonance imaging; Magnetic resonance spectroscopy; Skeletal muscle; T2 relaxation time

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; CHEMICAL COMPOSITION; CHILDHOOD DISEASE; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; DIXON IMAGING; ELASTOGRAPHY; FRACTIONAL ANISOTROPY; HUMAN; JUVENILE DERMATOMYOSITIS; MAGNETIC RESONANCE ELASTOGRAPHY; MORPHOLOGY; MUSCLE DISEASE; MUSCLE FAT FRACTION; MUSCLE RIGIDITY; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; RADIOLOGICAL PARAMETERS; REVIEW; SHEAR STIFFNESS; SHEAR WAVE; T1 WEIGHTED IMAGING; T2 RELAXATION TIME MAPPING; YOUNG MODULUS;

DIFFUSION TENSOR IMAGING; DIFFUSION-WEIGHTED IMAGING; DIXON IMAGING; MAGNETIC RESONANCE ELASTOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; SKELETAL MUSCLE; T2 RELAXATION TIME;

ADOLESCENT; CHILD; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCULAR DISEASES; SPECTRUM ANALYSIS;

EID: 84880027894     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2013.03.002     Document Type: Review

References (97)

1. May D.A., Disler D.G., Jones E.A., et al. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 2000, 20(Spec No):S295-S315.
2. Maillard S.M., Jones R., Owens C., et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004, 43(5):603-608.
3. Liu P., Hwang J.T. Quick calculation for sample size while controlling false discovery rate with application to microarray analysis. Bioinformatics 2007, 23(6):739-746.
4. Baur A., Reiser M.F. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol 2000, 29(10):555-562.
5. Kim H.K., Wang L.L., Merrow A.C., et al. Compounding factors affecting fat and water content of skeletal muscles in healthy children; objective measures using T2 relaxation time mapping (T2 Map) 2011, Radiological Society of North America, Chicago.
6. Arpan I., Forbes S.C., Lott D.J., et al. T(2) mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. NMR Biomed 2012, 26(3):320-328.
7. Gaeta M., Mileto A., Mazzeo A., et al. MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease. Skeletal Radiol 2012, 41(5):515-524.
8. Zaraiskaya T., Kumbhare D., Noseworthy M.D. Diffusion tensor imaging in evaluation of human skeletal muscle injury. JMagn Reson Imaging 2006, 24(2):402-408.
9. Sinha S., Sinha U., Edgerton V.R. Invivo diffusion tensor imaging of the human calf muscle. JMagn Reson Imaging 2006, 24(1):182-190.
10. Basford J.R., Jenkyn T.R., An K.N., et al. Evaluation of healthy and diseased muscle with magnetic resonance elastography. Arch Phys Med Rehabil 2002, 83(11):1530-1536.
11. Hsieh T.J., Wang C.K., Chuang H.Y., et al. Invivo proton magnetic resonance spectroscopy assessment for muscle metabolism in neuromuscular diseases. JPediatr 2007, 151(3):319-321.
12. Hsieh T.J., Jaw T.S., Chuang H.Y., et al. Muscle metabolism in Duchenne muscular dystrophy assessed by invivo proton magnetic resonance spectroscopy. JComput Assist Tomogr 2009, 33(1):150-154.
13. Kim H.K., Laor T., Racadio J.M. MR imaging assessment of the lateral head of the gastrocnemius muscle: prevalence of segmental anomalous origins in children and young adults. Pediatr Radiol 2008, 38(12):1300-1305.
14. Kim H.K., Laor T., Horn P.S., et al. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 2010, 255(3):899-908.
15. Bordalo-Rodrigues M., Rosenberg Z.S. MR imaging of the proximal rectus femoris musculotendinous unit. Magn Reson Imaging Clin N Am 2005, 13(4):717-725.
16. Kim H.K., Laor T., Graham T.B., et al. T2 relaxation time changes in distal femoral articular cartilage in children with juvenile idiopathic arthritis: a 3-year longitudinal study. AJR Am J Roentgenol 2010, 195(4):1021-1025.
17. Mercuri E., Pichiecchio A., Allsop J., et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. JMagn Reson Imaging 2007, 25(2):433-440.
18. Dardzinski B.J., Laor T., Schmithorst V.J., et al. Mapping T2 relaxation time in the pediatric knee:feasibility with a clinical 1.5-T MR imaging system. Radiology 2002, 225(1):233-239.
19. Patten C., Meyer R.A., Fleckenstein J.L. T2 mapping of muscle. Semin Musculoskelet Radiol 2003, 7(4):297-305.
20. Mugler J.P. Basic principles. Clinicalmagnetic resonance imaging 2006, 23-57. Saunders Elsevier, Philadelphia. 3rd edition. R.R. Edelman, J.R. Hesselink, M.B. Zlatkin (Eds.).
21. Gambarota G., Cairns B.E., Berde C.B., et al. Osmotic effects on the T2 relaxation decay of invivo muscle. Magn Reson Med 2001, 46(3):592-599.
22. Huang Y., Majumdar S., Genant H.K., et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. JMagn Reson Imaging 1994, 4(1):59-64.
23. Gold G.E., Han E., Stainsby J., et al. Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. AJR Am J Roentgenol 2004, 183(2):343-351.
24. Jordan C.D., Saranathan M., Bangerter N.K., et al. Musculoskeletal MRI at 3.0T and 7.0T: a comparison of relaxation times and image contrast. Eur J Radiol 2013, 82(5):734-739.
25. Stanisz G.J., Odrobina E.E., Pun J., et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005, 54(3):507-512.
26. Hazlewood C.F., Chang D.C., Nichols B.L., et al. Nuclear magnetic resonance transverse relaxation times of water protons in skeletal muscle. Biophys J 1974, 14(8):583-606.
27. Saab G., Thompson R.T., Marsh G.D. Multicomponent T2 relaxation of invivo skeletal muscle. Magn Reson Med 1999, 42(1):150-157.
28. Ladd P.E., Emery K.H., Salisbury S.R., et al. Juvenile dermatomyositis: correlation of MRI at presentation with clinical outcome. AJR Am J Roentgenol 2011, 197(1):W153-W158.
29. Johnson K., Davis P.J., Foster J.K., et al. Imaging of muscle disorders in children. Pediatr Radiol 2006, 36(10):1005-1018.
30. Wang L.L., Kim H.K., Merrow A.C., et al. MR imaging of the skeletal muscles in boys with Duchenne muscular dystrophy (DMD): part 1. Can fatty infiltration and inflammation of the gluteus maximus muscle be used as indicators of clinical assessment in boys with DMD? 2012, Society for Pediatric Radiology Meeting, San Francisco (CA).
31. Johnston J.H., Kim H.K., Merrow A.C., et al. MR imaging of the skeletal muscles in boys with Duchenne muscular dystrophy (DMD): part 2. T2Relaxation time mapping (T2 map) as a non-invasive biomarker to determine pathologic fatty infiltration: comparison between boys with Duchenne muscular dystrophy (DMD) and healthy boys 2012, Society for Pediatric Radiology Meeting, San Francisco (CA).
32. Fleckenstein J.L., Canby R.C., Parkey R.W., et al. Acute effects of exercise on MR imaging of skeletalmuscle in normal volunteers. AJR Am J Roentgenol 1988, 151(2):231-237.
33. Barger A.V., DeLone D.R., Bernstein M.A., et al. Fat signal suppression in head and neck imaging using fast spin-echo-IDEAL technique. AJNR Am J Neuroradiol 2006, 27(6):1292-1294.
34. Mito S., Ishizaka K., Nakanishi M., et al. Comparison of fat suppression techniques of bilateral breast dynamic sequence at 3.0 T: utility of three-point DIXON technique. Nihon Hoshasen Gijutsu Gakkai Zasshi 2011, 67(6):654-660. [in Japanese].
35. Sijens P.E., Edens M.A., Bakker S.J., et al. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 2010, 16(16):1993-1998.
36. Pykett I.L., Rosen B.R. Nuclear magnetic resonance: invivo proton chemical shift imaging. Work in progress. Radiology 1983, 149(1):197-201.
37. Ahmad M., Liu Y., Slavens Z.W., et al. Amethod for automatic identification of water and fat images from a symmetrically sampled dual-echo Dixon technique. Magn Reson Imaging 2010, 28(3):427-433.
38. Ma J. Dixon techniques for water and fat imaging. JMagn Reson Imaging 2008, 28(3):543-558.
39. Le-Petross H., Kundra V., Szklaruk J., et al. Fast three-dimensional dual echo Dixon technique improves fat suppression in breast MRI. JMagn Reson Imaging 2010, 31(4):889-894.
40. Cornfeld D.M., Israel G., McCarthy S.M., et al. Pelvic imaging using a T1W fat-suppressed 3-dimensional dual echo Dixon technique at 3T. JMagn Reson Imaging 2008, 28(1):121-127.
41. Gold G.E., Reeder S.B., Yu H., et al. Articular cartilage of the knee: rapid three-dimensional MR imaging at 3.0 T with IDEAL balanced steady-state free precession-initial experience. Radiology 2006, 240(2):546-551.
42. Wren T.A., Bluml S., Tseng-Ong L., et al. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190(1):W8-W12.
43. Kinali M., Arechavala-Gomeza V., Cirak S., et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011, 76(4):346-353.
44. Hajnal J.V., Doran M., Hall A.S., et al. MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathologic considerations. JComput Assist Tomogr 1991, 15(1):1-18.
45. Schaefer P.W., Grant P.E., Gonzalez R.G. Diffusion-weighted MR imaging of the brain. Radiology 2000, 217(2):331-345.
46. Le Bihan D., Breton E., Lallemand D., et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986, 161(2):401-407.
47. Turner R., Le Bihan D., Maier J., et al. Echo-planar imaging of intravoxel incoherent motion. Radiology 1990, 177(2):407-414.
48. Buxton R.B. The diffusion sensitivity of fast steady-state free precession imaging. Magn Reson Med 1993, 29(2):235-243.
49. Cui Y., Zhang X.P., Sun Y.S., et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008, 248(3):894-900.
50. Humphries P.D., Sebire N.J., Siegel M.J., et al. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 2007, 245(3):848-854.
51. Stieltjes B., Kaufmann W.E., van Zijl P.C., et al. Diffusion tensor imaging and axonal tracking in the human brainstem. Neuroimage 2001, 14(3):723-735.
52. Hoon A.H., Lawrie W.T., Melhem E.R., et al. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology 2002, 59(5):752-756.
53. Gilbert G., Simard D., Beaudoin G. Impact of an improved combination of signals from array coils in diffusion tensor imaging. IEEE Trans Med Imaging 2007, 26(11):1428-1436.
54. Le Bihan D., Mangin J.F., Poupon C., et al. Diffusion tensor imaging: concepts and applications. JMagn Reson Imaging 2001, 13(4):534-546.
55. Le Bihan D., van Zijl P. From the diffusion coefficient to the diffusion tensor. NMR Biomed 2002, 15(7-8):431-434.
56. Clark C.A., Le Bihan D. Water diffusion compartmentation and anisotropy at high b values in the human brain. Magn Reson Med 2000, 44(6):852-859.
57. Mori S., Crain B.J., Chacko V.P., et al. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999, 45(2):265-269.
58. Mori S., van Zijl P.C. Fiber tracking: principles and strategies-a technical review. NMR Biomed 2002, 15(7-8):468-480.
59. Basser P.J., Pajevic S., Pierpaoli C., et al. Invivo fiber tractography using DT-MRI data. Magn Reson Med 2000, 44(4):625-632.
60. Noseworthy M.D., Davis A.D., Elzibak A.H. Advanced MR imaging techniques for skeletal muscle evaluation. Semin Musculoskelet Radiol 2010, 14(2):257-268.
61. Sinha U., Yao L. Invivo diffusion tensor imaging of human calf muscle. JMagn Reson Imaging 2002, 15(1):87-95.
62. Toussaint N., Sermesant M., Stoeck C.T., et al. Invivo human 3D cardiac fibre architecture: reconstruction using curvilinear interpolation of diffusion tensor images. Med Image Comput Comput Assist Interv 2010, 13(Pt 1):418-425.
63. Gullberg G.T., Defrise M., Panin V.Y., et al. Efficient cardiac diffusion tensor MRI by three-dimensional reconstruction of solenoidal tensor fields. Magn Reson Imaging 2001, 19(2):233-256.
64. Zhang J., Zhang G., Morrison B., et al. Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy. Exp Neurol 2008, 212(2):448-457.
65. Serai S.D., Towbin A.J., Podberesky D.J. Pediatric liver MR elastography. Dig Dis Sci 2012, 57(10):2713-2719.
66. Tse Z.T., Janssen H., Hamed A., et al. Magnetic resonance elastography hardware design: a survey. Proc Inst Mech Eng H 2009, 223(4):497-514.
67. Muthupillai R., Lomas D.J., Rossman P.J., et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 1995, 269(5232):1854-1857.
68. Manduca A., Oliphant T.E., Dresner M.A., et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 2001, 5(4):237-254.
69. Dresner M.A., Rose G.H., Rossman P.J., et al. Magnetic resonance elastography of skeletal muscle. JMagn Reson Imaging 2001, 13(2):269-276.
70. Mason P. Dynamic stiffness and crossbridge action in muscle. Biophys Struct Mech 1977, 4(1):15-25.
71. Chen Q., Basford J., An K.N. Ability of magnetic resonance elastography to assess taut bands. Clin Biomech 2008, 23(5):623-629.
72. Brauck K., Galban C.J., Maderwald S., et al. Changes in calf muscle elasticity in hypogonadal males before and after testosterone substitution as monitored by magnetic resonance elastography. Eur J Endocrinol 2007, 156(6):673-678.
73. Debernard L., Robert L., Charleux F., et al. Analysis of thigh muscle stiffness from childhood to adulthood using magnetic resonance elastography (MRE) technique. Clin Biomech 2011, 26(8):836-840.
74. Debernard L., Robert L., Charleux F., et al. Characterization of muscle architecture in children and adults using magnetic resonance elastography and ultrasound techniques. JBiomech 2011, 44(3):397-401.
75. Domire Z.J., McCullough M.B., Chen Q., et al. Wave attenuation as a measure of muscle quality as measured by magnetic resonance elastography: initial results. JBiomech 2009, 42(4):537-540.
76. Papazoglou S., Hamhaber U., Braun J., et al. Horizontal shear wave scattering from a nonwelded interface observed by magnetic resonance elastography. Phys Med Biol 2007, 52(3):675-684.
77. Mariappan Y.K., Glaser K.J., Manduca A., et al. Cyclic motion encoding for enhanced MR visualization of slip interfaces. JMagn Reson Imaging 2009, 30(4):855-863.
78. Mariappan Y.K., Glaser K.J., Manduca A., et al. Vibration imaging for functional analysis of flexor muscle compartments. JMagn Reson Imaging 2009, 31:1395-1401.
79. Song J., Kwon O.I., Seo J.K. Anisotropic elastic moduli reconstruction in transversely isotropic model using MRE. Inverse Probl 2012, 28(11):115003.
80. Boesch C. Musculoskeletal spectroscopy. JMagn Reson Imaging 2007, 25(2):321-338.
81. Boesch C., Machann J., Vermathen P., et al. Role of proton MR for the study of muscle lipid metabolism. NMR Biomed 2006, 19(7):968-988.
82. Keeler J. Understanding NMR spectroscopy 2005, John Wiley & Sons, Chichester (West Sussex).
83. Provencher S.W. Estimation of metabolite concentrations from localized invivo proton NMR spectra. Magn Reson Med 1993, 30(6):672-679.
84. Naressi A., Couturier C., Devos J.M., et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001, 12(2-3):141-152.
85. 1H-MR-spectroscopy. Magn Reson Med 1997, 37(4):484-493.
86. 1H MR spectra of human muscle based on oral creatine supplementation. Magn Reson Med 1997, 37(2):159-163.
87. 1H spectroscopy of human skeletal muscle: normal and pathologic findings. Magn Reson Imaging 1992, 10(6):957-964.
88. de Graaf R.A. Invivo NMR spectroscopy: principles and techniques 2007, John Wiley & Sons, Chichester (West Sussex). 2nd edition.
89. Prompers J.J., Jeneson J.A., Drost M.R., et al. Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed 2006, 19(7):927-953.
90. 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy. Neuromuscul Disord 1997, 7(8):505-511.
91. Vorgerd M., Schols L., Hardt C., et al. Mitochondrial impairment of human muscle in Friedreich ataxia invivo. Neuromuscul Disord 2000, 10(6):430-435.
92. Park J.H., Niermann K.J., Ryder N.M., et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum 2000, 43(10):2359-2367.
93. Newman R.J., Bore P.J., Chan L., et al. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br Med J (Clin Res Ed) 1982, 284(6322):1072-1074.
94. Younkin D.P., Berman P., Sladky J., et al. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 1987, 37(1):165-169.
95. Kemp G.J., Taylor D.J., Dunn J.F., et al. Cellular energetics of dystrophic muscle. JNeurol Sci 1993, 116(2):201-206.
96. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. JNeurol Sci 1992, 109(2):188-195.
97. Torriani M., Townsend E., Thomas B.J., et al. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal Radiol 2012, 41(4):437-445.